Frédéric Gomez, Pharm.D

Exec. Director, Investor Relations

Frédéric Gomez has a broad expertise in the field of dry eye and cyclosporine especially in marketing, market access and market entry. He spent three years at Novagali Pharma S.A. where he was Head of Business Development and played a leading role in the sale of Novagali Pharma S.A. to Santen Pharmaceutical Co., Ltd. in 2011. Frédéric has worked several years as a Reseach Analyst with Bank BNP Paribas. He graduated from ESCP, Paris and holds a Pharm D. from Nantes University.